US2012115959A1PendingUtilityA1

Therapeutic Compositions And Methods

56
Assignee: CHIOU GEORGE CPriority: May 12, 2005Filed: Nov 23, 2011Published: May 10, 2012
Est. expiryMay 12, 2025(expired)· nominal 20-yr term from priority
A61P 43/00A61K 31/55A61P 27/02A61P 27/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates in general to therapeutic compositions and methods of use. In preferred embodiments, the invention relates to the field of eye health. In some embodiments, the invention relates to the prevention and treatment of macular degeneration by administering compounds disclosed herein. In some embodiments, the invention relates to compositions and methods of improving vision. The present invention includes compositions and methods that provide protection in a patient suffering from an eye disease such as age-related macular degeneration. In certain embodiments, the compositions of the present invention are administered during degeneration, and the composition includes an effective amount of an agent that increases choroidal blood flow.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . A method of treating macular degeneration comprising:
 1) providing
 i) a subject diagnosed with macular degeneration and 
 ii) a composition comprising guanabenz or salt thereof and 
   2) administering said compound to said subject.   
     
     
         16 . The method of  claim 15 , wherein said macular degeneration is age-related. 
     
     
         17 . The method of  claim 15 , wherein said subject is a human. 
     
     
         18 . The method above of  claim 15 , said administration is topically to the eye. 
     
     
         19 . The method above of  claim 15 , said salt is selected from the group of a hydrochloride salt and an acetate salt. 
     
     
         20 . The method of  claim 15 , wherein said composition is a liquid solution. 
     
     
         21 . A method of treating macular degeneration comprising:
 1) providing
 i) a subject diagnosed with macular degeneration and 
 ii) a composition comprising a substituted or unsubstituted compound of the following formula: 
   
       
         
           
           
               
               
           
         
         
            or salt thereof functioning to decrease choroidal neovascularization and 
         
         2) administering said compound to said subject.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.